Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer

NCT04897854 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreas Cancer

Interventions

DRUG: Folfirinox

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)